Mariner
AURA icon

Mariner’s Aura Biosciences AURA Stock Holding History

Mariner’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,663
Closed -$95.6K – 3052
2023
Q3 		$95.6K Sell
10,663
-5,118
-32% -$55.1K ﹤0.01% 2681
2023
Q2 		$195K Buy
15,781
+1,859
+13% +$19.9K ﹤0.01% 2478
2023
Q1 		$129K Buy
+13,922
New +$145K ﹤0.01% 2521

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCM
Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

Mariner's AURA Position: Q4 2023 in Review

Mariner sold out of Aura Biosciences (AURA) in Q4 2023, closing a stake of 10,663 shares — an estimated $95.6K sold.

Mariner first reported a position in AURA in Q1 2023 and held it in 3 quarters. The position peaked at $195K in Q2 2023. 72 funds tracked by Wall St. Rank hold AURA as of Q4 2023.

  • Mariner reported no remaining Aura Biosciences position as of Q4 2023 after selling out during the quarter.
  • Mariner sold 10,663 Aura Biosciences shares in Q4 2023, an estimated $95.6K.
  • Mariner first reported a position in Aura Biosciences in Q1 2023 and held it in 3 quarters.
  • Mariner's Aura Biosciences position peaked at $195K in Q2 2023.
  • 72 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2023.

Based on Mariner's 13F filing for Q4 2023, filed 14 Feb 2024.